Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
International collaborative treatment protocol for infants under one year with KMT2Arearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia
Protocol ID
Interfant21
Disease (Sub Disease)
Leukaemia
Diagnosis Stage
Newly diagnosed
Sponsor
Australian & New Zealand Children's Haematology/Oncology Group
Collaborators
Princess Maxima Center for Pediatric Oncology
Links
Trial Status
Preparing to Open
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 1 Year
International registry ID's
NCT05327894
| Study Title | International collaborative treatment protocol for infants under one year with KMT2Arearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia |
|---|---|
| Protocol ID | Interfant21 |
| Disease (Sub Disease) | Leukaemia |
| Diagnosis Stage | Newly diagnosed |
| Sponsor | Australian & New Zealand Children's Haematology/Oncology Group |
| Collaborators | Princess Maxima Center for Pediatric Oncology |
| Links | https://clinicaltrials.gov/study/NCT05327894 |
| Trial Status | Preparing to Open |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 1 Year |
| International registry ID's | NCT05327894 |